drugset / Trial / NCT01401985
A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
Non-randomizedSequentialSingle-blindTreatment
Summary
A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects with Opioid-Induced Constipation
Timeline
- Start
- 2011-10
- Primary completion
- 2012-05
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | axelopran | Small molecule | 2 mg | — |
| Subject | axelopran | Small molecule | 2.5 mg | — |
| Subject | axelopran | Small molecule | 10 mg | — |
| Subject | axelopran | Small molecule | 15 mg | — |